RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2024 -- It is with deep sadness that Pappas Capital announces the passing of Dr. Ernest Mario, Senior Venture Partner and one of the founders...
Chiesi Launches Venture Capital Fund via Strategic Collaboration with A. M. Pappas & Associates
News | 09. 02. 2014
Curzion Pharmaceuticals
Chiesi Launches Venture Capital Fund via Strategic Collaboration with A. M. Pappas & Associates
Strategic Collaboration to Focus on Rare Disease Early Stage Investment Opportunities
PARMA, Italy and RESEARCH TRIANGLE PARK, North Carolina, September 2, 2014 /PRNewswire/ -- The Chiesi Group announced today the launch of its venture capital fund, Chiesi Ventures, via a strategic collaboration with A. M. Pappas & Associates.
Chiesi Ventures will complement the strategic interest of the Chiesi Group in the area of rare diseases by investing in early stage opportunities and expanding the Chiesi network in the US among universities, venture capital investors, rare disease patient organizations and entrepreneurial companies developing treatments for rare diseases.
